342 related articles for article (PubMed ID: 29239349)
1. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
4. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.
Jirak P; Pistulli R; Lichtenauer M; Wernly B; Paar V; Motloch LJ; Rezar R; Jung C; Hoppe UC; Schulze PC; Kretzschmar D; Braun-Dullaeus RC; Bekfani T
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32326570
[TBL] [Abstract][Full Text] [Related]
6. Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity.
Sponder M; Lichtenauer M; Wernly B; Paar V; Hoppe U; Emich M; Fritzer-Szekeres M; Litschauer B; Strametz-Juranek J
J Investig Med; 2019 Jun; 67(5):833-840. PubMed ID: 30593542
[TBL] [Abstract][Full Text] [Related]
7. New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.
Dalos D; Spinka G; Schneider M; Wernly B; Paar V; Hoppe U; Litschauer B; Strametz-Juranek J; Sponder M
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252588
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight.
Jirak P; Wernly B; Lichtenauer M; Paar V; Franz M; Knost T; Abusamrah T; Kelm M; Muessig JM; Bimpong-Buta NY; Jung C
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423045
[TBL] [Abstract][Full Text] [Related]
9. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
Koller L; Stojkovic S; Richter B; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Wojta J; Hülsmann M; Niessner A
JACC Heart Fail; 2017 Apr; 5(4):268-277. PubMed ID: 28359415
[TBL] [Abstract][Full Text] [Related]
10. Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).
Mirna M; Wernly B; Paar V; Jung C; Jirak P; Figulla HR; Kretzschmar D; Franz M; Hoppe UC; Lichtenauer M; Lauten A
Biomarkers; 2018 Dec; 23(8):773-780. PubMed ID: 30041555
[TBL] [Abstract][Full Text] [Related]
11. Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure.
Rohm I; Kretzschmar D; Pistulli R; Franz M; Schulze PC; Stumpf C; Yilmaz A
J Immunol Res; 2016; 2016():6949320. PubMed ID: 27822484
[No Abstract] [Full Text] [Related]
12. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score.
Dupuy AM; Kuster N; Bargnoux AS; Aguilhon S; Huet F; Leclercq F; Pasquié JL; Roubille F; Cristol JP
Clin Chem Lab Med; 2021 Jun; 59(7):1299-1306. PubMed ID: 33544524
[TBL] [Abstract][Full Text] [Related]
13. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase-type plasminogen activator receptor represents exercise tolerance and predicts adverse cardiac events in patients with heart failure.
Ishikawa H; Izumiya Y; Shibata A; Ichikawa Y; Yamaguchi T; Yamaguchi Y; Kitada R; Iwata S; Ehara S; Tomita S; Hanatani A; Yoshiyama M
Heart Vessels; 2020 May; 35(5):681-688. PubMed ID: 31741050
[TBL] [Abstract][Full Text] [Related]
15. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Predictive Efficacy of Serum suPAR Combined with APN and IgE Test and the Relationship of Patients with CHF and Cardiac Function.
Tu S; Ye L; Shen C; Bai X; Li C
Altern Ther Health Med; 2024 Apr; 30(4):124-129. PubMed ID: 38581326
[TBL] [Abstract][Full Text] [Related]
17. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
18. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
19. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
